L.D. EGAMBERDIEVA¹, N.I. TUKHVATSHINA², L.M. MUKHAMETZYANOVA³

¹Republic Clinical Hospital of the MH of RT, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064

²Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012

 Egamberdieva L.D. ― Cand. Med. Sc., Associate Professor of the Department of obstetrics and gynecology №1, Doctor of the Gynecology Department, tel. +7-904-765-22-62, e-mail: [email protected]

Tukhvatshina N.I. ― Head of the Gynecology Department, tel. +7-903-313-71-78,  e-mail: [email protected]

Mukhametzyanova L.M. ― intern of the Department of obstetrics and gynecology №1, tel. +7-917-929-50-77, e-mail: [email protected]

A retrospective analysis of the course of pregnancy and delivery in 90 women was carried out. Pregnancy proceeded with complication in 70.4% of cases. It is shown that prolongation of pregnancy is possible if there are large and giant sizes of uterine fibroids. In pregnant women with fibroids of the uterus, fetoplacental insufficiency, delay in fetal development, preeclampsia is observed no more often than in pregnant women without uterine myoma. Pregnant women with uterine fibroids constitute a high-risk group, requiring careful pregravid preparation and special attention of a female consultation doctor.

Key words: uterine myoma, pregnancy, reproductive age.

REFERENCES

1. Mozheyko L.F., Lapotko M.L., Karbanovich V.O. Outcomes of pregnancy and childbirth in women with uterine myoma. Reproduktivnoe zdorov’e. Vostochnaya Evropa, 2012, no. 5, pp. 389-391 (in Russ.).
2. Mozheyko L.F. Modern aspects of etiopathogenesis and classification of uterine myoma. Reproduktivnoe zdorov’e. Vostochnaya Evropa, 2013, no. 1, pp. 56-61 (in Russ.).
3. Vikhlyaeva E.M. Rukovodstvo po diagnostike i lecheniyu bol’nykh leyomiomoy matki [Guide to diagnosis and treatment of patients with uterine leiomyoma]. Moscow: MEDpress-inform, 2004. 400 p.
4. Megley S. Modern aspects of the etiology and pathogenesis of uterine fibroids. Novye meditsinskie tekhnologii, 2005, no. 2, pp. 88-96 (in Russ.).
5. Mioma matki (sovremennye problemy etiologii, patogeneza, diagnostiki i lecheniya), pod red. I.S. Sidorovoy [Myoma of the uterus (modern problems of etiology, pathogenesis, diagnosis and treatment). Ed. by I.S. Sidorova]. Moscow, 2003. 256 p.
6. Brekhman G.I. Syndrome of psychoemotional stress and uterine myoma. Akusherstvo i ginekologiya, 1990, no. 2, pp. 13-17 (in Russ.).
7. Il’in V.I. Clinical features of mental disorders in gynecological patients with hormonal dysfunction and hormonal-dependent pathology . Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 1983, vol. 83, iss. 11, pp. 1691-1695 (in Russ.).
8. Buyanova S.N., Mgeliashvili M.V., Petrakova S.A. Modern ideas about the etiology, pathogenesis and morphogenesis of uterine fibroids. Rossiyskiy vestnik akushera-ginekologa, 2008, vol. 8, no. 6, pp. 45-50 (in Russ.).
9. Ginekologiya: uchebnik, pod red. G.M. Savel’evoy, V.G. Breusenko. 3-e izd., pererab. i dop. [Gynecology: a textbook. Edited by G.M. Savelieva, V.G. Breusenko. 3rd ed., revised and additional]. Moscow: GEOTAR-Media, 2007. 432 p.: il.
10. Lapotko M.L. Organosokhranyayushchee lechenie miomy matki: avtoref. dis. … kand. med. nauk [Organ-preserving treatment of uterine fibroids. Synopsis of dis. PhD med. sciences], 2010. 16 p.
11. Litvinova N.A., Nurullin R.F., Titchenko I.P., Dobrokhotova Yu.E. A modern organ-preserving method for treating patients with uterine myoma. Rossiyskiy vestnik akushera-ginekologa, 2009, vol. 9, no. 4, pp. 31-34 (in Russ.).
12. Savitskiy G.A., Savitskiy A.G. Mioma matki: problemy patogeneza i patogeneticheskoy terapii [Myoma of the uterus: problems of pathogenesis and pathogenetic therapy]. Saint Petersburg: ELBI-SPb, 2003. P. 236.
13. Savitskiy G.A. The role of local hyperestradiolemia in the pathogenesis of the onset and growth of uterine fibroids. Zhurnal akusherstva i zhenskikh bolezney, 2009, no. 4, pp. 79-93 (in Russ.).
14. Luoto R., Kaprio J., Rutanen E.M., Taipale P., Perola M., Koskenvuo M. Heritability and risk factors of uterine fibroids ― the Finnish Twin Cohort study. Maturitas, 2000. 37. Pp. 15-26.
15. Manyonda I., Sinthamoney E., Belli A.-M. Controversies and challenges in the modern management of uterine fibroids. Br. J. Obstet. Gynaecol, 2004, vol. 111, pp. 95-102.
16. Divakova T.S., Ivkova N.S., Medvedskaya S.E. Okhrana materinstva i detstva, 2005, no. 1, pp. 40-49 (in Russ.).
17. Samoylova T.E. Myoma of the uterus. Substantiation of nonoperative treatment. Problemy reproduktsii, 2003, vol. 9, no. 4, pp. 32-36 (in Russ.).
18. Vikhlyaeva E.M., Vasilevskaya L.N. Mioma matki [Myoma of the uterus]. Moscow, 1981. P. 156.
19. Samoylova T.E. Non-operative methods of treatment of uterine fibroids. Lechashchiy vrach, 2010, no. 3, pp. 53-60 (in Russ.).
20. Baird D.D., Dunson D.B. Why is parity protective for uterine fibroids? Epidemiology, 2003, vol. 14, pp. 247-250.
21. Dixon D., Flake G. P., Moore A.B. et al. Cell proliferation and apoptosis in human uterine leiomyomas and myometria. Virchows Arch, 2002, vol. 441, no. 1, pp. 53-62.
22. Faerstein E., Szklo M., Rosenshein N.B. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. American Journal of Epidemiology, 2001, 153, pp. 11-19.
23. Rein M.S. Advances in uterine leiomyoma research the progesterone hypothesis. Environ Health Perspect, 2000, vol. 108 (Suppl 5), pp. 791-793.
24. Wu X. Molecular mechanisms involved in the growth of human uterine leiomyoma. KarolinskaInstitutet, Stockholm, Sweden, 2002. Pp. 1-32.